GGrantIndex
← Leaderboards

Guoquan Zhang

University Of Missouri-Columbia

$6,252,823
Attributed
$6,526,438
Total exposure
9
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,526,438 · 9

By mechanism

R01$3,954,000 · 2
R21$2,040,520 · 5
R41$531,918 · 2

Top collaborators

Most similar at University Of Missouri-Columbia

Same institution · by research overlap

Others in their field

Top investigators on “Acute

Research focus

AcuteQ FeverChronicInfectionCoxiella BurnetiiGram-Negative BacteriaVaccinesLipopolysaccharidesPathogenAerosolsImmunityCellular ImmunityOrganismT-LymphocytePreventionBiosecurityNovel StrategiesMediatingVaccine CandidateCategoriesAntigensLeadFormalinBase

Grant awards (25)

Use a humanized monoclonal antibody as an emergency prophylactic and therapeutictreatment against human Q fever$301,674
R41 · FY2025 · AI · contact PI
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection$512,631
R01 · FY2021 · AI · contact PI
Mechanisms of B-1 Cell-Mediated Immunity Against Coxiella burnetii Infection$213,380
R21 · FY2021 · AI · contact PI
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection$520,516
R01 · FY2020 · AI · contact PI
IDENTIFY NOVEL NEUTRALIZATION-SENSITIVE EPITOPES OF COXIELLA BURNETII$224,750
R21 · FY2020 · AI · contact PI
Mechanisms of B-1 Cell-Mediated Immunity Against Coxiella burnetii Infection$177,447
R21 · FY2020 · AI · contact PI
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection$526,723
R01 · FY2019 · AI · contact PI
Use of mimotope vaccine technology to develop vaccines against bacterial pathogens$230,244
R41 · FY2019 · AI · contact PI
IDENTIFY NOVEL NEUTRALIZATION-SENSITIVE EPITOPES OF COXIELLA BURNETII$186,875
R21 · FY2019 · AI · contact PI
Use of a Humanized Antibody against Intracellular Bacterial Pathogen$186,875
R21 · FY2019 · AI · contact PI
ROLE OF DENDRITIC CELLS IN REGULATING VACCINE- INDUCED IMMUNITY AGAINST Q FEVER$124,795
R21 · FY2019 · AI · contact PI
Role of Dendritic Cells in Regulating Vaccine- Induced Immunity Against Q Fever$66,203
R21 · FY2019 · AI · contact PI
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection$10,254
R01 · FY2019 · AI · contact PI
Identify Novel Neutralization-Sensitive Epitopes of Coxiella burnetii$5,224
R21 · FY2019 · AI · contact PI
Use of a Humanized Antibody Against Intracellular Bacterial Pathogen$4,125
R21 · FY2019 · AI · contact PI
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection$536,977
R01 · FY2018 · AI · contact PI
Role of Dendritic Cells in Regulating Vaccine- Induced Immunity Against Q Fever$228,100
R21 · FY2018 · AI · contact PI
Use of a Humanized Antibody Against Intracellular Bacterial Pathogen$228,100
R21 · FY2018 · AI · contact PI
Development of O Antigen-based Vaccines Against Q Fever$375,233
R01 · FY2015 · AI · contact PI
Development of O Antigen-based Vaccines Against Q Fever$374,630
R01 · FY2014 · AI · contact PI
Development of O Antigen-based Vaccines Against Q Fever$350,077
R01 · FY2013 · AI · contact PI
Development of O Antigen-based Vaccines Against Q Fever$373,600
R01 · FY2012 · AI · contact PI
Development of O Antigen-based Vaccines Against Q Fever$373,359
R01 · FY2011 · AI · contact PI
The Role of Antibody-Mediated Protective Immunity Against Q fever$180,064
R21 · FY2010 · AI · contact PI
The Role of Antibody-Mediated Protective Immunity Against Q fever$214,582
R21 · FY2009 · AI · contact PI